Zarema E. Gilazieva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zarema E. Gilazieva has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Albert Anatolyevich Rizvanov
Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia
1 shared publication - Shaza S. Issa
Department of Genetics and Biotechnology, St. Petersburg State University, 199034 St. Petersburg, Russia
1 shared publication - Valeriya Vladimirovna Solovyeva
Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia
1 shared publication - Vladislava V. Pipiya
Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia
1 shared publication
Latest Publications
- Open Access
- 17 May 2024
- Published by Open Exploration Publishing in Exploration of Targeted Anti-tumor Therapy
- Vol. 5 (3) , 581-599
Comparison of primary and passaged tumor cell cultures and their application in personalized medicine
Passaged cell lines represent currently an integral component in various studies of malignant neoplasms. These cell lines are utilized for drug screening both in monolayer cultures or as part of three-dimensional (3D) tumor models. They can also be used to model the tumor microenvironment in vitro and in vivo through xenotransplantation into immunocompromised animals. However, immortalized cell lines have some limitations of their own. The homogeneity of cell line populations and the extensive passaging in monolayer systems make these models distant from the original disease. Recently, there has been a growing interest among scientists in the use of primary cell lines, as these are passaged directly from human tumor tissues. In this case, cells retain the morphological and functional characteristics of the tissue from which they were derived, an advantage often not observed in passaged cultures. This review highlights the advantages and limitations of passaged and primary cell cultures, their similarities and differences, as well as existing test systems that are based on primary and passaged cell cultures for drug screening purposes.
- 17 May 2024
- Published by Open Exploration Publishing in Exploration of Targeted Anti-tumor Therapy
- Vol. 5 (3) , 581-599
Open AccessComparison of primary and passaged tumor cell cultures and their application in personalized medicine
Passaged cell lines represent currently an integral component in various studies of malignant neoplasms. These cell lines are utilized for drug screening both in monolayer cultures or as part of three-dimensional (3D) tumor models. They can also be used to model the tumor microenvironment in vitro and in vivo through xenotransplantation into immunocompromised animals. However, immortalized cell lines have some limitations of their own. The homogeneity of cell line populations and the extensive passaging in monolayer systems make these models distant from the original disease. Recently, there has been a growing interest among scientists in the use of primary cell lines, as these are passaged directly from human tumor tissues. In this case, cells retain the morphological and functional characteristics of the tissue from which they were derived, an advantage often not observed in passaged cultures. This review highlights the advantages and limitations of passaged and primary cell cultures, their similarities and differences, as well as existing test systems that are based on primary and passaged cell cultures for drug screening purposes.